A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of Ridinalazole for 10 days with Vancomycin for 10 days in the treatment of Clostridium difficile (C Diff) Infection

By |2019-04-24T18:12:28+00:00April 24th, 2019|